LIBRELEASE Drug Patent Profile
Which patents cover Librelease, and when can generic versions of Librelease launch?
Librelease is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in LIBRELEASE is chlordiazepoxide. There is one drug master file entry for this compound. Additional details are available on the chlordiazepoxide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LIBRELEASE?
- What are the global sales for LIBRELEASE?
- What is Average Wholesale Price for LIBRELEASE?
Summary for LIBRELEASE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4,549 |
| DailyMed Link: | LIBRELEASE at DailyMed |
US Patents and Regulatory Information for LIBRELEASE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | LIBRELEASE | chlordiazepoxide | CAPSULE, EXTENDED RELEASE;ORAL | 017813-001 | Sep 12, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIBRELEASE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | LIBRELEASE | chlordiazepoxide | CAPSULE, EXTENDED RELEASE;ORAL | 017813-001 | Sep 12, 1983 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
